We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+101.42%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$669M
AUM Growth
+$482M
Cap. Flow
+$394M
Cap. Flow %
58.85%
Top 10 Hldgs %
31.65%
Holding
214
New
153
Increased
2
Reduced
1
Closed
16

Top Buys

Rank Stock Value
1
NKLA
Nikola Corporation Common Stock
NKLA
+$32.1M
2
TMUS icon
T-Mobile US
TMUS
+$29.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$22.7M
4
DKNG icon
DraftKings
DKNG
+$17.3M
5
PCG icon
PG&E
PCG
+$12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$127M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$17.7M
3
FEAC.U
Flying Eagle Acquisition Corp. Units, each consisting of one share of Class A common stock and one-f
FEAC.U
+$5.98M
4
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
+$5M
5
ADC icon
Agree Realty
ADC
+$2.17M

Sector Composition

Rank Sector Weight
1 Healthcare 32.46%
2 Consumer Discretionary 19.77%
3 Communication Services 8.34%
4 Technology 8.26%
5 Financials 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLDX icon
51
Celldex Therapeutics
CLDX
$3.28B
$3.9M 0.58%
+300,000
New +$1.33M
MLAB icon
52
Mesa Laboratories
MLAB
$574M
$3.79M 0.57%
+17,500
New +$4.03M
SITM icon
53
SiTime
SITM
$21.8B
$3.79M 0.57%
+80,000
New +$2.37M
LQDA icon
54
Liquidia Corp
LQDA
$8.02B
$3.79M 0.57%
+450,000
New +$3.41M
CSTL icon
55
Castle Biosciences
CSTL
$979M
$3.77M 0.56%
+100,000
New +$3.42M
ARCT icon
56
Arcturus Therapeutics
ARCT
$211M
$3.72M 0.56%
+79,497
New +$2.74M
ONEM
57
DELISTED
1Life Healthcare
ONEM
$3.63M 0.54%
+100,000
New +$2.82M
VRM icon
58
Vroom Inc
VRM
$48.2M
$3.58M 0.53%
+858
New +$3.33M
TPTX
59
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$3.55M 0.53%
+55,000
New +$3.17M
WMG icon
60
Warner Music
WMG
$13.8B
$3.54M 0.53%
+120,000
New +$3.74M
TMC icon
61
TMC The Metals Company
TMC
$1.98B
$3.54M 0.53%
+350,000
New +$3.41M
PRVB
62
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$3.53M 0.53%
+250,000
New +$3.16M
SRC
63
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$3.49M 0.52%
+100,000
New +$3.03M
ARYBU
64
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
$3.48M 0.52%
+300,000
New +$3.3M
WPC icon
65
W.P. Carey
WPC
$16.4B
$3.38M 0.51%
+51,050
New +$3.17M
ARGX icon
66
argenx
ARGX
$54.1B
$3.38M 0.51%
+15,000
New +$2.66M
QTS
67
DELISTED
QTS REALTY TRUST, INC.
QTS
$3.27M 0.49%
+51,000
New +$3.21M
YETI icon
68
Yeti Holdings
YETI
$3.95B
$3.26M 0.49%
+76,238
New +$2.29M
TMDX icon
69
Transmedics
TMDX
$2.91B
$3.14M 0.47%
+175,000
New +$2.74M
JWS.U
70
DELISTED
Jaws Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one red
JWS.U
$3.13M 0.47%
+300,000
New +$3.12M
EDIT icon
71
Editas Medicine
EDIT
$442M
$3.11M 0.46%
+105,000
New +$2.74M
FATE icon
72
Fate Therapeutics
FATE
$326M
$3.09M 0.46%
+90,000
New +$2.68M
IIPR icon
73
Innovative Industrial Properties
IIPR
$1.72B
$3.08M 0.46%
+35,000
New +$2.85M
TME icon
74
Tencent Music
TME
$15.6B
$3.03M 0.45%
+225,000
New +$2.66M
TLMD
75
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$3.01M 0.45%
300,000
– –
1 2
3
4 5

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Monashee Investment Management held 214 positions worth $669M, up 258% from $187M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Monashee Investment Management deployed $394M of net new capital in Q2 2020, opening 153 new positions and adding to 2 existing holdings. Its largest new stake was Nikola Corporation Common Stock: 33,333 shares worth $67.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 5.2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Molecular Templates, Inc., an estimated $1.46M trimmed.

  • Monashee Investment Management's largest Q2 2020 buy was Nikola Corporation Common Stock: 33,333 shares worth $67.5M.
  • Monashee Investment Management added most to DermTech, Inc. Common Stock in Q2 2020, an estimated $930K increase.
  • Monashee Investment Management's biggest Q2 2020 reduction was Molecular Templates, Inc., cutting an estimated $1.46M.
  • Monashee Investment Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2020, selling an estimated $127M.
  • Monashee Investment Management's ten largest holdings make up 32% of its $669M portfolio in Q2 2020.
  • Monashee Investment Management opened 153 new positions and closed 16 in Q2 2020.
  • Monashee Investment Management's portfolio value rose 258% quarter-over-quarter to $669M.

Based on Monashee Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.